Prosecution Insights
Last updated: October 27, 2026

Nicola Maria Bauer, USPTO Patent Examiner

Listed by the USPTO as BAUER, NICOLA MARIA

Tech Center 1600 • Art Units: 1621 1629 1684

This examiner grants 59% of resolved cases

Analysis

Nicola Maria Bauer works in tech center 1600 and art unit 1621. Her record includes 63 resolved cases, an allowance rate of 58.7%, and a median of 1353 days to allowance. The interview lift is 52.1%, indicating a strong association between interviews and allowance outcomes in the available record. The smaller case history means the result should be applied with attention to matter-specific facts.

The leading companies are Alcon Inc., The Board of Trustees of the Leland Stanford Junior University, and Opella Healthcare Group SAS. The leading firms are Casimir Jones, S.C., FULLER IP LAW LLC, and Apex Attorneys at Law, LLP. Practitioners may consider interview preparation a central part of prosecution planning. The allowance rate and median timing also support early evaluation of claim scope and continuation options.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

58.7%
Allow Rate
-1.3% vs TC avg
102
Total Applications
+52.1%
Interview Lift
1353
Avg Prosecution Days
Based on 63 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
21.5%
§102 Novelty
48.8%
§103 Obviousness
13.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18557899 STABLE ISOQUINOLINE-CORTICOSTEROID CONJUGATES AND USES THEREOF Non-Final OA ALCON INC.
18257167 CB2 RECEPTOR AGONISTS Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18041475 METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18063048 BINDING SITE IN TYPE 2 RYANODINE RECEPTOR Non-Final OA The Trustees of Columbia University in the City of New York
18576970 STERICALLY MODIFIED SCHIFF BASE LIGANDS FOR ENHANCED CATALYTIC CARBONYLATION ACTIVITY Non-Final OA Novomer LLC
17799609 HETEROCYCLIC GLP-1 AGONISTS Non-Final OA Gasherbrum Bio, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Nicola Maria Bauer's allowance rate?

58.7% of resolved applications examined by Nicola Maria Bauer were allowed (63 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.

Does an interview help with examiner Nicola Maria Bauer?

This examiner's interview lift is +52.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Nicola Maria Bauer take to allow a patent?

Applications allowed by Nicola Maria Bauer took 1,353 days on average from filing to allowance.

Which art unit does examiner Nicola Maria Bauer work in?

Nicola Maria Bauer examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month